0.2161
price up icon8.65%   0.0172
after-market Handel nachbörslich: .22 0.0039 +1.80%
loading
Schlusskurs vom Vortag:
$0.1989
Offen:
$0.19
24-Stunden-Volumen:
1.68M
Relative Volume:
1.12
Marktkapitalisierung:
$15.57M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.92M
KGV:
-0.4237
EPS:
-0.51
Netto-Cashflow:
$-18.92M
1W Leistung:
-9.47%
1M Leistung:
-34.30%
6M Leistung:
-79.99%
1J Leistung:
-87.58%
1-Tages-Spanne:
Value
$0.1831
$0.2364
1-Wochen-Bereich:
Value
$0.1814
$0.2397
52-Wochen-Spanne:
Value
$0.1814
$2.39

Cel-Sci Corp. Stock (CVM) Company Profile

Name
Firmenname
Cel-Sci Corp.
Name
Telefon
703-506-9460
Name
Adresse
8229 Boone Boulevard, Suite 802, Vienna, VA
Name
Mitarbeiter
0
Name
Twitter
@CelSciCorp
Name
Nächster Verdiensttermin
2025-02-18
Name
Neueste SEC-Einreichungen
Name
CVM's Discussions on Twitter

Vergleichen Sie CVM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CVM
Cel-Sci Corp.
0.2161 15.57M 0 -26.92M -18.92M -0.51
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 125.40B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 65.79B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 35.18B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 32.67B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 26.46B 3.81B -644.79M -669.77M -6.24

Cel-Sci Corp. Stock (CVM) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2020-01-13 Eingeleitet H.C. Wainwright Buy
2015-03-02 Eingeleitet Dawson James Buy

Cel-Sci Corp. Aktie (CVM) Neueste Nachrichten

pulisher
Mar 31, 2025

CVM stock touches 52-week low at $0.23 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

CVM stock touches 52-week low at $0.23 amid sharp annual decline - Investing.com Australia

Mar 31, 2025
pulisher
Mar 29, 2025

CEL-SCI (NYSE:CVM) Earns Sell Rating from Analysts at StockNews.com - Defense World

Mar 29, 2025
pulisher
Mar 24, 2025

Breakthrough: New Cancer Drug Delivers 95% Quality of Life Improvement for Head & Neck Patients - Stock Titan

Mar 24, 2025
pulisher
Mar 21, 2025

CVM stock touches 52-week low at $0.26 amid sharp annual decline - Investing.com Australia

Mar 21, 2025
pulisher
Mar 21, 2025

CVM stock touches 52-week low at $0.26 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 21, 2025
pulisher
Mar 21, 2025

Cel-Sci Corp (CVM) Volatility Hits 12.01%: What Good Investors Need To Be Aware Of - Stocks Register

Mar 21, 2025
pulisher
Mar 18, 2025

CEL-SCI announces closing of $2.5 million offering -March 18, 2025 at 05:23 pm EDT - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

CEL-SCI Secures $2.5M Funding: Major Push for FDA-Designated Cancer Immunotherapy - StockTitan

Mar 18, 2025
pulisher
Mar 18, 2025

Why Harrow Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 18, 2025
pulisher
Mar 17, 2025

CEL-SCI Secures Critical Funding for FDA-Approved Head & Neck Cancer Treatment Study - StockTitan

Mar 17, 2025
pulisher
Mar 17, 2025

CEL-SCI advances in head and neck cancer treatment study - Investing.com

Mar 17, 2025
pulisher
Mar 17, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Mar 17, 2025
pulisher
Mar 17, 2025

CEL-SCI advances in head and neck cancer treatment study By Investing.com - Investing.com UK

Mar 17, 2025
pulisher
Mar 17, 2025

CEL-SCI’s Head and Neck Cancer Registration Study Protocol Clears FDA Review—in Talks with Potential Partners Interested in Commercialization of Multikine - Yahoo Finance

Mar 17, 2025
pulisher
Mar 15, 2025

Cel-Sci Corp (CVM) Recovers 5.85% From Low: Are We There Yet? - Stocks Register

Mar 15, 2025
pulisher
Mar 14, 2025

Major Breakthrough: JAMA Study Shows Multikine Triples Survival Rates in Head and Neck Cancer - StockTitan

Mar 14, 2025
pulisher
Mar 13, 2025

CEL-SCI (NYSE:CVM) Coverage Initiated at StockNews.com - Defense World

Mar 13, 2025
pulisher
Mar 10, 2025

CVM stock touches 52-week low at $0.31 amid sharp annual decline - Investing.com Australia

Mar 10, 2025
pulisher
Mar 10, 2025

CVM stock touches 52-week low at $0.31 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 05, 2025

4 Biotech Stocks To Watch: CVM, NKGN, NBIO, IMUX - DRP Journal

Mar 05, 2025
pulisher
Mar 05, 2025

CEL-SCI Announces That NYSE MKT Granted an Extension to Regain Compliance - AOL

Mar 05, 2025
pulisher
Feb 28, 2025

CVM Stock Hits 52-Week Low at $0.33 Amid Steep Annual Decline - Investing.com Australia

Feb 28, 2025
pulisher
Feb 27, 2025

CVM Stock Hits 52-Week Low at $0.33 Amid Steep Annual Decline By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 26, 2025

CEL-SCI (NYSE:CVM) Now Covered by StockNews.com - Armenian Reporter

Feb 26, 2025
pulisher
Feb 20, 2025

CEL-SCI advances Multikine study for head and neck cancer - Investing.com

Feb 20, 2025
pulisher
Feb 20, 2025

CEL-SCI advances Multikine study for head and neck cancer By Investing.com - Investing.com UK

Feb 20, 2025
pulisher
Feb 20, 2025

CEL-SCI to Initiate Multikine Confirmatory Phase 3 Cancer Trial -February 20, 2025 at 08:06 am EST - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

CEL-SCI to Initiate Multikine Confirmatory Phase 3 Cancer Trial - Yahoo Finance

Feb 20, 2025
pulisher
Feb 19, 2025

CEL-SCI Reports Fiscal Q1 2025 Financial Results: Multikine Shows Pre-Surgical Tumor Elimination and Regression in Just 3 Weeks - BioSpace

Feb 19, 2025
pulisher
Feb 18, 2025

StockNews.com Begins Coverage on CEL-SCI (NYSE:CVM) - Armenian Reporter

Feb 18, 2025
pulisher
Feb 18, 2025

Breakthrough Cancer Treatment Shows 73% Survival Rate: CEL-SCI's Latest Clinical Milestone - Stock Titan

Feb 18, 2025
pulisher
Feb 17, 2025

CEL-SCI (NYSE:CVM) Now Covered by Analysts at StockNews.com - Defense World

Feb 17, 2025
pulisher
Feb 15, 2025

Cel-Sci: Fiscal Q1 Earnings Snapshot - mySA

Feb 15, 2025
pulisher
Feb 14, 2025

Cel-Sci: Fiscal Q1 Earnings Snapshot -February 14, 2025 at 04:25 pm EST - Marketscreener.com

Feb 14, 2025
pulisher
Feb 10, 2025

CVM: Fiscal Year 2024 Results - Research Tree

Feb 10, 2025
pulisher
Feb 03, 2025

LD Micro 360 Companies Set to Present this Week - ACCESS Newswire

Feb 03, 2025
pulisher
Jan 27, 2025

Personal Finance - Business Wire

Jan 27, 2025
pulisher
Jan 21, 2025

Short Interest in DoubleLine Income Solutions Fund (NYSE:DSL) Increases By 8.7% - Defense World

Jan 21, 2025
pulisher
Jan 20, 2025

Have A Relaxing Holiday Season - MENAFN.COM

Jan 20, 2025
pulisher
Jan 18, 2025

Cantex Mine Development (CVE:CD) Stock Price Up 9.5% – Should You Buy? - Defense World

Jan 18, 2025
pulisher
Jan 14, 2025

CEL-SCI Reports Fiscal 2024 Results: Set to Commence Confirmatory Study That Could Bring New Standard of Care to Head & Neck Cancer - Yahoo Finance

Jan 14, 2025
pulisher
Jan 13, 2025

Pre-market Movers: AVGR, TIVC, ATNF, SLGL... - RTTNews

Jan 13, 2025
pulisher
Jan 09, 2025

CVM stock touches 52-week low at $0.37 amid sharp annual decline - Investing.com Nigeria

Jan 09, 2025

Finanzdaten der Cel-Sci Corp.-Aktie (CVM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$60.26
price down icon 10.70%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Kapitalisierung:     |  Volumen (24h):